Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $602.8100 (-2.85%) ($602.3850 - $602.8100) on Mon. Dec. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.94% (three month average) | RSI | 41 | Latest Price | $602.8100(-2.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.8% a day on average for past five trading days. | Weekly Trend | REGN advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) DIA(40%) XLV(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.97% in a week (0% probabilities). VIXM(-19%) TBT(-10%) UUP(-8%) VXX(-4%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.97% (StdDev 1.94%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $643.21 | 5 Day Moving Average | $636.54(-5.3%) | 10 Day Moving Average | $646.24(-6.72%) | 20 Day Moving Average | $643.21(-6.28%) | To recent high | -10.1% | To recent low | 11.1% | Market Cap | $63.915b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |